Chicago Partners Investment Group
XERS icon

Chicago Partners Investment Group’s Xeris Biopharma Holdings XERS Stock Holding History

Chicago Partners Investment Group’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$96.1K Sell
11,425
-2,068
-15% -$13.2K ﹤0.01% 1485
2026
Q1 		$81.5K Buy
+13,493
New +$89.5K ﹤0.01% 1398

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Chicago Partners Investment Group's XERS Position: Q2 2026 in Review

Chicago Partners Investment Group reduced its Xeris Biopharma Holdings (XERS) stake by 15% in Q2 2026, selling an estimated $13.2K and leaving 11,425 shares worth $96.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1485.

Chicago Partners Investment Group first reported a position in XERS in Q1 2026 and has held it in 2 quarters since. 240 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • Chicago Partners Investment Group held 11,425 shares of Xeris Biopharma Holdings worth $96.1K as of Q2 2026.
  • Chicago Partners Investment Group sold 2,068 Xeris Biopharma Holdings shares in Q2 2026, an estimated $13.2K.
  • Xeris Biopharma Holdings made up ﹤0.01% of Chicago Partners Investment Group's portfolio in Q2 2026, its #1485 holding.
  • Chicago Partners Investment Group first reported a position in Xeris Biopharma Holdings in Q1 2026 and has held it in 2 quarters since.
  • 240 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Chicago Partners Investment Group's 13F filing for Q2 2026, filed 30 Jul 2026.